Anthropic on October 27, 2026 published a progress update on its life sciences work, reporting early results from research partnerships with six drug development organizations — BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group — alongside its first in-house drug programs. The company said its strategy is to involve Claude across the drug development process, from target identification and molecule design to manufacturing…